Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Research and Development

Content :

Pipeline

January 21, 2013

Sanofi has a vigorous pipeline of potential new medicines in key therapy areas of unmet patient need, with 65 projects in research & development. The majority are biological products and vaccines, with more than half being compounds from external research partnerships.

 

Therapies in advanced stages of clinical development or in the process of seeking marketing approval include:

  • Treatment of familial hypercholesterolemia in the EU

  • Treatment of relapsing multiple sclerosis in the EU and the U.S.

  • Treatment of type 2 diabetes in the EU

  • Treatment of metastatic colorectal cancer in the EU

Module :

Corporate Information

Corporate Information

 

History

History

Sanofi has a rich history of innovation dating back more than 100 years.